Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Operating Activities
Net Income	$ 587	$ 587
Net Income	583	595
Adjustments to reconcile Net Income to Net cash from operating activities:
Depreciation and amortization	601	553
Nuclear fuel amortization	30	25
Allowance for equity funds used during construction	(13)	(13)
Deferred income taxes	80	80
Equity earnings of equity method investees	(43)	(53)
Dividends from equity method investees	89	34
Asset (gains) losses and impairments, net	13	0
Changes in assets and liabilities:
Accounts receivable, net	369	20
Inventories	46	104
Prepaid postretirement benefit costs	(38)	(9)
Accounts payable	(247)	(34)
Gas inventory equalization	45	37
Accrued pension liability	(122)	(197)
Accrued postretirement liability	0	(61)
Derivative assets and liabilities	(20)	(8)
Regulatory assets and liabilities	142	230
Other current and noncurrent assets and liabilities	(152)	138
Net cash from operating activities	1,367	1,433
Investing Activities
Plant and equipment expenditures — utility	(1,294)	(1,027)
Plant and equipment expenditures — non-utility	(102)	(130)
Proceeds from sale of nuclear decommissioning trust fund assets	396	616
Investment in nuclear decommissioning trust funds	(399)	(613)
Distributions from equity method investees	5	5
Contributions to equity method investees	(38)	(233)
Notes receivable	(62)
Notes receivable		5
Other	(20)	(3)
Net cash used for investing activities	(1,514)	(1,380)
Financing Activities
Issuance of long-term debt, net of issuance costs	1,438	520
Redemption of long-term debt	0	(102)
Short-term borrowings, net	(606)	(147)
Issuance of common stock	0	6
Dividends paid on common stock	(345)	(309)
Contributions from noncontrolling interests, principally REF entities	17	22
Distributions to noncontrolling interests	(31)	(17)
Purchases of noncontrolling interest, principally SGG	(300)	0
Other	(40)	(29)
Net cash from (used for) financing activities	133	(56)
Net Decrease in Cash, Cash Equivalents, and Restricted Cash	(14)	(3)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	76	89
Cash, Cash Equivalents, and Restricted Cash at End of Period	62	86
Supplemental disclosure of non-cash investing and financing activities
Plant and equipment expenditures in accounts payable	270	216
DTE Electric
Operating Activities
Net Income	280	303
Adjustments to reconcile Net Income to Net cash from operating activities:
Depreciation and amortization	450	414
Nuclear fuel amortization	30	25
Allowance for equity funds used during construction	(12)	(9)
Deferred income taxes	38	91
Asset (gains) losses and impairments, net	13	0
Changes in assets and liabilities:
Accounts receivable, net	53	(86)
Inventories	(12)	24
Accounts payable	(13)	(2)
Accrued pension liability — affiliates	(105)	(182)
Accrued postretirement liability — affiliates	(24)	(47)
Regulatory assets and liabilities	137	158
Other current and noncurrent assets and liabilities	(169)	(4)
Net cash from operating activities	666	685
Investing Activities
Plant and equipment expenditures	(1,073)	(825)
Proceeds from sale of nuclear decommissioning trust fund assets	396	616
Investment in nuclear decommissioning trust funds	(399)	(613)
Notes receivable	(5)	0
Other	(19)	(4)
Net cash used for investing activities	(1,100)	(826)
Financing Activities
Issuance of long-term debt, net of issuance costs	643	520
Short-term borrowings, net — affiliate	194	(41)
Short-term borrowings, net — other	(149)	(108)
Dividends paid on common stock	(247)	(230)
Other	(16)	(7)
Net cash from (used for) financing activities	425	134
Net Decrease in Cash, Cash Equivalents, and Restricted Cash	(9)	(7)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	18	15
Cash, Cash Equivalents, and Restricted Cash at End of Period	9	8
Supplemental disclosure of non-cash investing and financing activities
Plant and equipment expenditures in accounts payable	$ 159	$ 117